Bosnian oncology patient advocacy group demands urgent revision of national drug reimbursement list

The 'Renesansa' association has publicly pressured the Federation of Bosnia and Herzegovina government to update the essential drug list, citing a seven-year delay in access to critical oncology treatments. The protest highlights systemic failures in pharmaceutical procurement and healthcare policy that directly impact patient survival rates.